Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Feb;40(2):460–463. doi: 10.1128/aac.40.2.460

beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca.

B Fournier 1, P H Lagrange 1, A Philippon 1
PMCID: PMC163134  PMID: 8834898

Abstract

beta-Lactamase gene promoters of 45 clinical Klebsiella oxytoca isolates resistant to beta-lactams and exhibiting beta-lactamase hyperproduction differed from those in 26 susceptible strains. Direct sequencing revealed one mutation in either the -10 or -35 conserved sequences: a G-to-A transition of the fifth base (67%) or a G-to-T transversion of the first base of the -10 sequence (27%) or a T-to-A transversion in the fourth base in the -35 sequence (4%). One strain carried both the -10 transition and the -35 transversion.

Full Text

The Full Text of this article is available as a PDF (297.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anraku Y. The reduction and restoration of galactose transport in osmotically shocked cells of Escherichia coli. J Biol Chem. 1967 Mar 10;242(5):793–800. [PubMed] [Google Scholar]
  2. Arakawa Y., Ohta M., Kido N., Mori M., Ito H., Komatsu T., Fujii Y., Kato N. Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother. 1989 Jan;33(1):63–70. doi: 10.1128/aac.33.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buirma R. J., Horrevorts A. M., Wagenvoort J. H. Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study. Scand J Infect Dis Suppl. 1991;78:35–44. [PubMed] [Google Scholar]
  4. Fournier B., Arlet G., Lagrange P. H., Philippon A. Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase. FEMS Microbiol Lett. 1994 Feb 1;116(1):31–36. doi: 10.1111/j.1574-6968.1994.tb06671.x. [DOI] [PubMed] [Google Scholar]
  5. Fournier B., Lu C. Y., Lagrange P. H., Krishnamoorthy R., Philippon A. Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca. Antimicrob Agents Chemother. 1995 Jun;39(6):1365–1368. doi: 10.1128/aac.39.6.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fournier B., Roy P. H., Lagrange P. H., Philippon A. Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2. Antimicrob Agents Chemother. 1996 Feb;40(2):454–459. doi: 10.1128/aac.40.2.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hawley D. K., McClure W. R. Compilation and analysis of Escherichia coli promoter DNA sequences. Nucleic Acids Res. 1983 Apr 25;11(8):2237–2255. doi: 10.1093/nar/11.8.2237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jaurin B., Grundström T., Normark S. Sequence elements determining ampC promoter strength in E. coli. EMBO J. 1982;1(7):875–881. doi: 10.1002/j.1460-2075.1982.tb01263.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kobayashi M., Nagata K., Ishihama A. Promoter selectivity of Escherichia coli RNA polymerase: effect of base substitutions in the promoter -35 region on promoter strength. Nucleic Acids Res. 1990 Dec 25;18(24):7367–7372. doi: 10.1093/nar/18.24.7367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Livermore D. M. beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995 Oct;8(4):557–584. doi: 10.1128/cmr.8.4.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Monnet D., Freney J. Method for differentiating Klebsiella planticola and Klebsiella terrigena from other Klebsiella species. J Clin Microbiol. 1994 Apr;32(4):1121–1122. doi: 10.1128/jcm.32.4.1121-1122.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Paul G., Barthélémy M., Philippon A., Peduzzi J., Gilly L., Labia R., Névot P. Immunological comparison of constitutive beta-lactamases of gram-negative bacteria by neutralization in zymogram gels: properties of anti-TEM-1 and anti-TEM-2 sera. Ann Inst Pasteur Microbiol. 1988 Jul-Aug;139(4):435–451. [PubMed] [Google Scholar]
  13. Shah P. M., Asanger R., Kahan F. M. Incidence of multi-resistance in gram-negative aerobes from intensive care units of 10 German hospitals. Scand J Infect Dis Suppl. 1991;78:22–34. [PubMed] [Google Scholar]
  14. Sirot D. L., Goldstein F. W., Soussy C. J., Courtieu A. L., Husson M. O., Lemozy J., Meyran M., Morel C., Perez R., Quentin-Noury C. Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother. 1992 Aug;36(8):1677–1681. doi: 10.1128/aac.36.8.1677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Snydman D. R. Clinical implications of multi-drug resistance in the intensive care unit. Scand J Infect Dis Suppl. 1991;78:54–63. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES